All lobbying filings

THE CONSILIO GROUP

Lobbying for N BRERETON MEDICAL TECHNOLOGIES · Opiod prevention through a titration-based methodology.

Filing Registration

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 22, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Virginia

Official filing document

Lobbyists on this filing 2

OLIVER MEISSNER New on this filing

Previously held: CEO
BRANDON KIRBY New on this filing

Previously held: Director of Government Relations

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 1

Alcohol and Drug Abuse

FenBlock️, a novel solution to the opioid crisis through a data-driven, titration-based methodology. FenBlock uses a graduated dose barrier to manage substance dependency with precision, providing a controlled and effective path to recovery.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.